BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25502838)

  • 1. Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism.
    Chen S; Wang L; Fan J; Ye C; Dominguez D; Zhang Y; Curiel TJ; Fang D; Kuzel TM; Zhang B
    Cancer Res; 2015 Feb; 75(3):519-31. PubMed ID: 25502838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2.
    Beury DW; Carter KA; Nelson C; Sinha P; Hanson E; Nyandjo M; Fitzgerald PJ; Majeed A; Wali N; Ostrand-Rosenberg S
    J Immunol; 2016 Apr; 196(8):3470-8. PubMed ID: 26936880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment.
    Wallecha A; Singh R; Malinina I
    J Immunother; 2013; 36(9):468-76. PubMed ID: 24145358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
    Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C
    Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
    Tsukamoto H; Nishikata R; Senju S; Nishimura Y
    Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
    Younis RH; Han KL; Webb TJ
    J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.
    Serafini P; Meckel K; Kelso M; Noonan K; Califano J; Koch W; Dolcetti L; Bronte V; Borrello I
    J Exp Med; 2006 Nov; 203(12):2691-702. PubMed ID: 17101732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.
    Noman MZ; Janji B; Hu S; Wu JC; Martelli F; Bronte V; Chouaib S
    Cancer Res; 2015 Sep; 75(18):3771-87. PubMed ID: 26206559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
    Sevko A; Sade-Feldman M; Kanterman J; Michels T; Falk CS; Umansky L; Ramacher M; Kato M; Schadendorf D; Baniyash M; Umansky V
    J Invest Dermatol; 2013 Jun; 133(6):1610-9. PubMed ID: 23223128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells.
    Yu H; Liu Y; McFarland BC; Deshane JS; Hurst DR; Ponnazhagan S; Benveniste EN; Qin H
    Cancer Immunol Res; 2015 Jul; 3(7):727-40. PubMed ID: 25649351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
    Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
    J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies.
    Hossain F; Al-Khami AA; Wyczechowska D; Hernandez C; Zheng L; Reiss K; Valle LD; Trillo-Tinoco J; Maj T; Zou W; Rodriguez PC; Ochoa AC
    Cancer Immunol Res; 2015 Nov; 3(11):1236-47. PubMed ID: 26025381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
    Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
    Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
    Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
    J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.
    Zhong H; Gutkin DW; Han B; Ma Y; Keskinov AA; Shurin MR; Shurin GV
    Int J Cancer; 2014 Jun; 134(11):2633-45. PubMed ID: 24443321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.
    Tebartz C; Horst SA; Sparwasser T; Huehn J; Beineke A; Peters G; Medina E
    J Immunol; 2015 Feb; 194(3):1100-11. PubMed ID: 25548227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of arginase-2 expression in dendritic cells by microRNA-155 is critical for promoting T cell proliferation.
    Dunand-Sauthier I; Irla M; Carnesecchi S; Seguín-Estévez Q; Vejnar CE; Zdobnov EM; Santiago-Raber ML; Reith W
    J Immunol; 2014 Aug; 193(4):1690-700. PubMed ID: 25009204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.